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In vitro differentiation of embryonic stem (ES) cells is often used to study hematopoiesis. However, the differentiation pathway
of lymphocytes, in particular natural killer (NK) cells, from ES cells is still unclear. Here, we used a multi-step in vitro ES cell
differentiation system to study lymphocyte development from ES cells, and to characterize NK developmental intermediates.
We generated embryoid bodies (EBs) from ES cells, isolated CD34
+ EB cells and cultured them on OP9 stroma with a cocktail of
cytokines to generate cells we termed ES-derived hematopoietic progenitors (ES-HPs). EB cell subsets, as well as ES-HPs
derived from EBs, were tested for NK, T, B and myeloid lineage potentials using lineage specific cultures. ES-HPs derived from
CD34
+ EBs differentiated into NK cells when cultured on OP9 stroma with IL-2 and IL-15, and into T cells on Delta-like 1-
transduced OP9 (OP9-DL1) with IL-7 and Flt3-L. Among CD34
+ EB cells, NK and T cell potentials were detected in a CD45
2
subset, whereas CD45
+ EB cells had myeloid but not lymphoid potentials. Limiting dilution analysis of ES-HPs generated from
CD34
+CD45
2 EB cells showed that CD45
+Mac-1
2Ter119
2 ES-HPs are highly enriched for NK progenitors, but they also have T, B
and myeloid potentials. We concluded that CD45
2CD34
+ EB cells have lymphoid potential, and they differentiate into more
mature CD45
+Lin
2 hematopoietic progenitors that have lymphoid and myeloid potential. NK progenitors among ES-HPs are
CD122
2 and they rapidly acquire CD122 as they differentiate along the NK lineage.
Citation: Tabatabaei-Zavareh N, Vlasova A, Greenwood CP, Takei F (2007) Characterization of Developmental Pathway of Natural Killer Cells from
Embryonic Stem Cells In Vitro. PLoS ONE 2(2): e232. doi:10.1371/journal.pone.0000232
INTRODUCTION
Natural killer (NK) cells are a lymphocyte population that plays an
important role in the innate immune system. They are
characterized by their natural cytotoxicity against tumor cells
and virus-infected cells, but they are also an important source of
cytokines. Unlike T and B cells, NK cells do not express antigen-
specific receptors generated by the somatic rearrangement of
receptor genes. Instead, they express various combinations of
inhibitory and stimulating receptors to recognize a broad range of
target cells [1]. NK lineage committed precursors (NKPs) that
differentiate into NK cells but not other hematopoietic cells have
been identified in adult mouse bone marrow (BM) by the surface
phenotype of Lin
2CD122 (IL-2Rb)
+ [2], and the developmental
processes from NKPs to mature NK cells have been described in
detail [3]. On the other hand, the developmental pathway from
hematopoietic stem cells (HSCs) to NKPs is still unclear. It is
generally thought that all lymphocytes derive from common
lymphoid progenitors (CLPs) identified by the surface phenotype
of Lin
2c-kit
loSca-1
loIL-7Ra
+ in BM [4]. However, bipotent T/
NK progenitors in fetal liver, blood and thymus give rise to both
NK and T cells but not B cells [5–7]. Some fetal T/NKP
progenitors are also identified as IL-7R
+ [6,8], suggesting that the
expression of IL-7R is a critical stage in lymphocyte development
in both adult and fetal environment.
In vitro differentiation of embryonic stem (ES) cells provides
a powerful model system to study lymphocyte development from
hematopoietic progenitors. Embryoid bodies (EBs) generated from
ES cells in vitro contain CD34
+ cells that have both myeloid and
lymphoid potential [9]. B cells [9–12], NK cells [9], and T cells
[13,14] have also been generated from ES cells in vitro. In most
studies, ES cells were co-cultured on OP9 stromal cell line to
generate cells of the hematopoietic lineage [10,12,13]. However,
the differentiation pathways from ES cells to lymphocytes and the
intermediate progenitors have not been characterized in detail. It
is important to isolate hematopoietic precursors with lymphoid
potential from ES cells, because lymphomyeloid precursors from
ES cells could be used as the potential source of reconstituting
HSCs in the treatment for leukemia and a range of genetic
disorders.
We have previously established a multi-step culture system to
induce ES cell differentiation into NK cells. In this system, ES cells
were induced to form EBs, and CD34
+ hematopoietic progenitors
isolated from EBs were cultured with OP9 and cytokines for
differentiation into ES-derived hematopoietic progenitors (ES-
HPs), which subsequently differentiate into NK cells [15]. No
other lymphocytes are generated in this culture system. Here, we
used this ES culture system to characterize NK cell progenitors at
different steps in development and examined the relationship
between NK and other lymphoid lineages.
MATERIALS AND METHODS
Cell lines, antibodies and flow cytometry
OP9 cells were obtained from RIKEN (Tokyo, Japan). OP9 cells
transduced with Delta-like1 and green fluorescent protein (OP9-
DL1) were kind gift from Dr. J-C Zuniga Pflucker (Toronto,
Canada). 2.4G2 (anti-FcRc), FITC-conjugated and purified anti-
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PLoS ONE | www.plosone.org 1 February 2007 | Issue 2 | e232mouse Ly5.2 (CD45.2) and Ly5.1, biotinylated anti-Mac-1 (M1/
70), and Gr-1 (RB6-8C5) mAbs have been described [16,17].
Biotinylated anti-CD34 (RAM34), and IL-7Ra (A7R34) mAbs
were purchased from eBioscience (San Diego, CA). FITC-
conjugated anti-CD34 (RAM34), purified anti-CD31
(MEC13.3), phycoerythrin (PE)-conjugated anti-CD25 (3C7), IL-
2Rb (TM-b1), and Sca-1 (E13-161.7) mAbs, biotinylated anti-
bodies to mouse c-kit (2B8), CD31 (MEC-13.3), common c-chain
(cc) (TUGm2), CD94 (18d3), NKG2A/C/E (20d5), TCRcd
(GL3), CD3e (145-2C11), CD44 (1M7), CD4 (GK1.5), Ter119,
B220 (RA3-6B2), CD19 (1D3), streptavidin-APC, -PE, -FITC,
and proper isotype control antibodies were purchased from BD-
Biosciences (Mississauga, ON). Biotinylated anti-mouse TCRab
(H57-597) mAb was purchased from Cedarlane (Ontario,
Canada). PE-conjugated anti-mouse CD8a (53-6.7) mAb was
purchased from Boehringer Mannheim Biochemica. Secondary
antibodies goat anti-mouse IgG and goat anti-rat IgG labeled with
Alexa Flour 647 were obtained from Molecular Probes (Eugene,
OR). For all cell stainings and sortings, cells were first pre-
incubated with 2.4G2 hybridom supernatant or human c globulin
(Sigma-Aldrich) to block Fc-receptors, followed by primary mAbs.
All incubations were performed on ice for 30 min and stained cells
were analyzed on a FACSCalibur (BD Biosciences, San Jose, CA)
with the CellQuest Pro software (BD Biosciences). Cell sorting was
carried out on a FACSVantage
TM SE (BD Biosciences).
ES cell culture
The ES cell line R1 (129/SvJ strain) was maintained as described
[15]. On the day of differentiation, cells were harvested,
resuspended at 1,500–2,000 cells/ml in the differentiation medi-
um consisting of IMDM, 15% FBS, 1% methylcellulose, 2 mM L-
glutamine, 150 mM MTG, 50 ng/ml mouse stem cell factor (SCF),
30 ng/ml mouse IL-3, and 30 ng/ml human IL-6, and 1 ml of the
cell suspension was dispensed into 35 mm petri dish (StemCell
Technologies, Vancouver, Canada). The cells were incubated at
37uC and 5% CO2 for 8 days for EB formation. EBs were then
harvested, trypsinized and made into single-cell suspension by
passing them through a 21-gauge 1K-inch needle three times.
Subsequently, the cells were stained with biotinylated anti-CD34
followed by streptavidin-PE and FITC conjugated anti-CD45.2 or
purified CD45.2 followed by Alexa Flour 647-conjugated goat anti-
mouse IgG, and sorted on FACSVantage
TM SE (BD, San Jose, CA)
for isolation of CD34
+,C D 3 4
+CD45
2 and CD34
+CD45
+ EB cells.
EB cells were then seeded onto OP9 stroma in 24-well plates at
a concentration of 4610
4 cells/well and cultured for 7 days with
30 ng/ml IL-6, 4 ng/ml IL-7, 40 ng/ml SCF, and 100 ng/ml Flt3-
Ligand (Flt3-L) (Stem Cell Technologies) to generate ES-HPs. After
the first 3–4 days of incubation, half the media was replaced with
fresh medium containing the same cytokines. ES-HPs were
harvested on day 7 by vigorous pipetting, washed, and passed
through a 45 mm filter. Cells were then transferred onto lineage-
specific cultures or stained for FACS analysis.
Lineage differentiation cultures
OP9 and OP9-DL1 cells were incubated for 2 days in 24 well
plates to pre-form stroma layers. For NK differentiation cultures,
EB cells or ES-HPs were plated on OP9 layers in OP9 media
(aMEM supplemented with 10% FBS) containing 1,000 U/ml IL-
2 (PeproTech, Rock Hill, NJ) and 5 ng/ml IL-15 (StemCell
Technologies). Cells were cultured for 7–14 days before FACS
analysis. For T cell culture, EB or ES-HP cells were seeded onto
OP9-DL1 stroma with 5 ng/ml IL-7, and 10 ng/ml Flt3-L and
cultured for 8–14 days. After this period, media was removed from
the culture and replaced with media containing Flt3-L and 1 ng/
ml IL-7. Cells were cultured for additional 3–6 days and harvested
for FACS analysis or RNA extraction. For B cell culture, ES-HP
cells were cultured on OP9 stroma with 5 ng/ml IL-7 and 10 ng/
ml Flt3-L for one week. In all of these cultures, stromal cells were
replaced with new cells if the culture period was longer than one
week. To test the myeloid colony forming capacity of EB or ES-
HP cells, cells were resuspended in IMDM, transferred onto
Methocult
TM GF M3434 media (StemCell Technologies) at the
density of 1000/plate in duplicate and cultured for 7–14 days. The
numbers of all colonies including erythroid burst-forming units
(BFU-E), granulocyte-macrophage colonies (CFU-GM/CFU-G/
CFU-M), and erythrocyte-containing mixed colony-forming units
(CFU-GEMM) were scored.
RT-PCR
RNA from bulk cells was isolated with QIAGEN’s RNeasyH Mini
Kit and reverse transcribed into cDNA using QIAGEN’s
Omniscript Reverse Transcription kit. For samples from limiting
dilution cultures, cells in 96-well plates were lysed with 50 ml
guanidinium isothiocyanate solution, RNA was isolated (as
described [18]) and reverse transcribed using a 18-mer oligo
(dT) primer (1 mg/ml) (New England BioLabs, Pickering, OT) and
Superscript
TM II (Invitrogen, Carlsbad, CA). Aliquots (1/5) of
cDNA thus generated were used in PCR reaction. Forward
primers from TCR Vc2, 3, 4, and 5, and reverse primer from the
TCRc constant region have been described [19]. The primer
sequences were as follows: granzyme B (forward) 59-CAAAGG-
CAGGGGAGATCATC-39, (reverse) 59-CTCTTCAGCTT-
TAGCAGCATG-39; CD3e (forward) 59-GCCTCAGAAGCAT-
GATAAGC-39, (reverse) 59-AGACTGCTCTCTGATTCAGG-
39; RAG-1 (forward) 59-TGCAGACATTCTAGCACTCTGG-
39, (reverse) 59-ACATCTGCCTTCACGTCGAT-39; GAPDH
(forward) 59-TCAACGACCCCTTCATTGACCTC-39, (reverse)
59-AGACTCCACGACATACTCAGCAC-39. The PCR thermo-
cycling conditions for TCRc RT-PCR were as follows: 5 min at
96uC followed by 40 cycles of 96uC for 15 s, 50uC for 40 s, 72uC
for 1 min, and a final 10 min extension at 72u. The following
condition was used for granzyme B RT-PCR: 1 min at 94uC
followed by 40 cycles of 94uC for 30 s, 60uC for 30 s, and 72uC for
30 s. 18 ml of PCR products from bulk cultures were mixed with
2 mlo f1 0 6loading buffer and analyzed on 1.2% agarose gel. The
gel from TCRc RT-PCR was alkaline blotted to ZetaProbe
membranes (Bio-Rad, Hercules, CA). In limiting dilution experi-
ments, the entire TCRc PCR products from multiple samples
were transferred onto ZetaProbe membranes using Bio-DotH
Microfiltration apparatus (Bio-Rad). The membrane was probed
with biotin-labeled oligonucleotides and visualized by North2-
SouthH Chemiluminescent Nucleic Acid hybridization and De-
tection Kit (Pierce, Rockford, IL). The 39 end of oligonucleotide
was labeled with biotin-14-dATP according to Invitrogen pro-
tocol. The probe sequence was: Jc1: 59-TGCAAATACCTTGT-
GAAAACCTGAG-39.
Limiting dilution analysis
OP9 and OP9-DL1 cells were X-ray irradiated (30Gy) and pre-
incubated for 2 days in 96 well plates. Limiting numbers of cells
were deposited into 96-well plates using the CloneCyt Plus option
of FACVantage
TM SE cell sorter. To determine NK progenitor
frequency, cells were cultured for 10–12 days on pre-formed OP9
stroma in IL-2 and IL-15. For T progenitor frequency, cells were
cultured on pre-formed OP9-DL1 stroma with 5 ng/ml IL-7 and
10 ng/ml Flt3-L for 10–12 days. Cells were then cultured with
NK Development from ES Cells
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RNA was isolated from cells as described in RT-PCR section.
RNA thus generated was reverse transcribed into cDNA and used
in PCR reaction. The presence of NK cells was confirmed by
granzyme B RT-PCR (data not shown). To identify T cells by RT-
PCR, a mixture of TCR Vc2, 3, 4, and 5 primers was paired with
a reverse primer from TCRc constant region. Rearranged TCRc
transcripts were detected by southern blotting (see above and data
not shown) [19]. Progenitor frequency was determined using L-
Calc
TM software (StemCell Technologies).
RESULTS
NK and T cell potentials of ES-HPs
The previously described ES cell culture system [15] was slightly
modified and used in this study (depicted in Fig. 1A). Briefly, R1
ES cells were cultured in methylcellulose for 8 days for EB
formation. CD34
+ EB cells were sorted and cultured on OP9
stromal cells with SCF, Flt3-L, IL-7 and IL-6 for 7 days. The cells
generated in this culture, termed ES-HPs, further differentiated
into NK cells upon co-culturing with OP9 in the presence of IL-2
and IL-15. The NK cells derived from ES cells (ES-NK cells)
expressed CD94, NKG2A/C/E receptors on the surface as well as
granzyme B transcipts (Fig. 1A, B and Table 1). We have
previously shown that similar to fetal NK cells, ES-NK cells lack
Ly49 expression but express NKRP1A (CD161) mRNA and are
capable of differentially killing some tumor cell lines and MHC
class I-deficient lymphoblasts [15]. To test whether ES-HPs have
potential for the T cell lineage, they were co-cultured with OP9
stroma expressing Delta-like1 (OP9-DL1 cells), which promotes T
cell differentiation from progenitors [20], in the presence of IL-7
and Flt3-L for 8–12 days. RT-PCR analysis of the resultant cells
showed the expression of rearranged TCRc mRNA (Fig. 1C) as well
as CD3e and RAG1 mRNA (Fig. 1D). Moreover, flow cytometric
analysisshowedthesurfaceexpressionofTCRbandTCRc(Fig.1E).
Thus, ES-HPs included T cell progenitors. ES-HPs were also tested
for the myeloid differentiation potential by in vitro colony forming
cell assays. The ES-HP population contained very low frequency of
erythroid/myeloid colony forming cells (Fig. 1F).
To further characterize lymphoid progenitors among the ES-
HP population, we analyzed the expression of markers associated
with BM lymphoid progenitors. Flow cytometric analysis showed
that most ES-HPs expressed c-kit whereas only very small fractions
expressed IL-7Ra (CD127), common c chain (cc, CD132), IL-2Ra
(CD25) and IL-2Rb (CD122) (Fig. 2A). Furthermore, only 10% of
ES-HPs expressed CD45, suggesting that the majority of the ES-
HPs are non-hematopoietic or mature erythroid cells. As expected,
cells expressing IL-7Ra and cc were enriched in the CD45
+ subset
of ES-HPs (Fig. 2B). Limiting dilution culture analysis for NK
progenitors showed that on average 0.5% (1 in 202) of the bulk
ES-HPs differentiate into NK cells. As expected, NK progenitors
were more enriched in CD45
+ ES-HPs (1 in 53 or 1.9%) than in
CD45
2 ES-HPs (1 in 286) (Fig. 2C) (Table 1).
Heterogeneity of CD34
+ EB cells: CD34
+CD4
2 EB
cells have lymphoid potential
The above results showed that the ES-HP population was very
heterogeneous, containing hematopoietic and possibly non-hemato-
poietic (e.g. endothelial) cells, and the frequency of NK progenitors
among ES-HPs was low. To determine whether this is due to
heterogeneity ofCD34
+ EBcell population that gave riseto ES-HPs,
we analyzed the expression of various hematopoietic cell markers on
CD34
+ EB cells (Fig. 3A). Large fractions of CD34
+ cells expressed
the hematopoietic progenitor-associated markers c-kit (65%) and
Sca-1 (35%), and almost all expressed CD31, a marker for
endothelial cells [21] and erythroid progenitors [22]. No significant
levels of IL-7Ra (CD127) and mature hematopoietic lineage
markers, including Mac-1, Gr-1, Ter119, B220, CD19, CD3 and
CD8 were detected on CD34
+ EB cells. Approximately 15–25% of
CD34
+ EB cells expressed the pan-leukocyte marker CD45.
We fractionated CD34
+ EB cells into CD45
+ and CD45
2
subsets by FACS sorting and analyzed for myeloid/erythroid and
lymphoid potentials. Both populations contained comparable
frequencies of myeloid/erythroid colony forming cells (Fig. 3C).
When they were cultured on OP9 stroma in the presence of SCF,
Flt3-L, IL-7 and IL-6 for 7 days to generate ES-HPs and examined
for the myeloid potential, the frequency of myeloid/erythroid
colony forming cells in CD45
+ EB-derived ES-HPs was signifi-
cantly higher than that of CD34
+CD45
2 EB-derived cells.
However, CD45
+ EB cells or those cultured for ES-HP generation
did not differentiate into NK, T or B cells upon co-culturing with
OP9 or OP9-DL1 in the presence of appropriate cytokines (see
materials and methods). In contrast, CD34
+CD45
2 EB cells
cultured under the same conditions differentiated into NK and T
cells (Fig. 3D, E). Limiting dilution analysis showed that on
average 1 in 633 CD34
+CD45
2 EB cells differentiated into NK
cells, while frequency of T progenitors was 1 in 1266 (Fig. 3F)
(Table 1). No NK or T cell progenitors were detected among
CD45
+ EB cells by limiting dilution analysis (data not shown).
These results indicate that lymphoid potential is contained in the
CD45
2CD34
+ EB cell population whereas CD45
+ EB cells have
erythroid/myeloid but not lymphoid potential. Analysis of Mac-1
expression on CD34
+ EB cells showed that in contrast to CD45
2
subset, CD45
+ subsets are Mac-1
+, suggesting that the latter are
committed myeloid precursors (Fig. 3B).
NK cell progenitors among ES-HPs derived from
CD34
+CD45
2 EB cells
The above results showed CD34
+CD45
2 EB cells have lymphoid
potentials but the frequencies of NK and T cell progenitors were
rather low. Therefore, we generated ES-HPs from CD34
+CD45
2
EB cells and analyzed them for cell surface marker expression and
lymphoid differentiation potentials. Flow cytometric analysis
showed that the cells generated in vitro from CD34
+CD45
2 EB
cells were again heterogeneous and included large fractions
expressing c-kit, Sca-1, and CD31 whereas IL-7R was almost
undetectable. Cells expressing the erythroid marker Ter119 and
the myeloid cell marker Mac-1 (CD11b, CD18) were also detected
(Fig. 4A). Only 13% of the cells were CD45
+ (Fig. 4A), which
included cells co-expressing c-kit and Sca-1 and those expressing
Mac-1 and/or Ter119 (Fig. 4B).
NK potential of ES-HPs generated from CD34
+CD45
2 EB
cells was first tested by bulk cultures. NK cells expressing CD94
and NKG2A/C/E were readily generated in cultures on OP9
stroma (data not shown). Limiting dilution analysis showed that
NK progenitors are highly enriched in the CD45
+Lin
2 (Mac-
1
2Ter119
2) subset of ES-HPs. In three experiments, the
frequency of NK progenitors in this population was on average
about 10% (1 in 10), ranging from 14% (1 in 7) to 4% (1 in 24) in
three experiments (Fig. 4E), which is comparable to the frequency
of NK progenitors in the BM NKP (Lin
2CD122
+) population [2],
whereas the NK progenitor frequency of the bulk ES-HP
population was on average 0.4% (1 in 230) (Table 1). As the
CD45
+Lin
2 subset is about 5% of the total ES-HP population,
most NK progenitors seemed enriched in this subset of ES-HPs.
However, CD45
+Lin
2 ES-HPs were different from BM-derived
NKPs, as they do not express detectable level of IL-2Rb (CD122)
NK Development from ES Cells
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+Lin
2 ES-HPs were sorted and
cultured with IL-2 and IL-15 for three days, IL-2Rb was detected
on the cultured cells (Fig. 4C). CD45
+Lin
2 ES-HP cells became
mature CD94
+ and NKG2A/C/E
+ NK cells after one week in the
NK differentiation culture (Fig. 4D).
ES-HPs derived from CD34
+CD45
2 EB cells have T
and B cell potentials
To test whether ES-HPs derived from CD34
+CD45
2 EB cells
have T cell differentiation potential, they were cultured on OP9-
Figure 1. ES-HPs have NK and T cell potentials with little myeloid potential. (A) ES culture system to generate ES-HPs is illustrated. ES cells are
induced to form EBs in methylcellulose. CD34
+ EBs are sorted and cultured for one week with OP9 stroma in the presence of indicated cytokines to
generate ES-HP cells. ES-HPs are cultured on OP9 stroma with IL-2 and IL-15 for NK cell differentiation or on OP9-DL1 stroma with IL-7 and Flt3-L for T
cell differentiation. (B) NK cells generated from ES-HPs were stained for the indicated receptors and analyzed by flow cytometer. Filled histograms
show staining with the appropriate mAbs and open histograms show isotype-matched control antibody staining. Percentages of positively stained
cells over the control staining are shown. Dead cells were stained with propidium iodide and gated out. Residual OP9 cells were also gated out by
their high scatter profile. (C) RNA was isolated from 2610
5 bulk T cells and 2610
6 bulk NK cells derived from ES-HPs (ES-T and ES-NK, respectively) and
converted into cDNAs. Aliquots (1/30) of cDNAs were subjected to PCR for rearranged TCRc gene. The PCR products were blotted and hybridized to
aJ c1 probe. Thymocytes were used as positive control. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RT-PCR was also used as control. (D)
cDNA was generated from ES-T cells as in (C). One microlitre of undiluted, 1/10 and 1/100 diluted cDNA was subjected to PCR for CD3e and RAG-1.
OP9 cells were used as negative control. (E) ES-T cells were harvested on day 7, stained for TCRcd and TCRb and analyzed by flow cytometer as in Fig.
1B. OP9-DL1 cells expressed green fluorescent protein and were gated out by green fluorescence. (F) One thousand CD34
+ EBs and ES-HP cells were
plated in methylcellulose media for myeloid and erythroid colony formation and the total number of myeloid and erythroid colonies were counted as
described in materials and methods.
doi:10.1371/journal.pone.0000232.g001
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analyzed the expression of CD44 and CD25 at different time
points during the culture (Fig. 5A) as these markers are commonly
used to define the early steps of immature double negative (DN,
CD4
2CD8
2) thymocyte differentiation [23]. The cells initially
resembled the most immature thymocyte population DN1
(CD4
2CD8
2CD44
+CD25
2). After one week of culture, some
(,8%) of the cells acquired CD25 and resembled DN2
(CD4
2CD8
2CD44
+CD25
+) thymocytes. After two weeks, the
level of CD44 on DN2-like cells decreased and they resembled
DN3 (CD4
2CD8
2CD44
2CD25
+) thymocytes. Prolonged culture
did not induce a further differentiation into the DN4
(CD4
2CD8
2CD44
2CD25
2) population. Although CD44
2CD25
2
cells were detected early in the cultures (week one and two), they
seemed to directly derive from the DN1-like cells without going
through the DN2 and DN3 stages. Very few cells expressing CD4,
CD8 or CD3 were generated in this culture (data not shown). It
appeared that T cell development from ES-HPs was impaired at the
transition from DN3 to DN4. This may be due to a high dose of IL-
7, which has been reported to block differentiation of adult
progenitors into T cells [24,25]. Therefore, after 8–14 days of
culture,theIL-7concentrationwasreducedto1 ng/ml,andthecells
were cultured for an additional 4–6 days with OP9-DL1. Cells
expressing CD4, CD8 and the TCR were detected in the low-dose
IL-7 culture (Fig. 5B, C). However, the expression levels of CD4 and
CD8 were significantly lower than those on thymocytes (data not
shown), and very few double positive (CD4
+CD8
+) and single
positive (CD4
+CD8
2 and CD4
2CD8
+) cells were generated.
Limiting dilution analysis showed that the frequency of T cell
progenitors was approximately 0.3% (1 in 297) in the bulk ES-HP
population and 0.9% (1 in 115) in the CD45
+Lin
2 subset of ES-
HPs (Fig. 5D). Thus, T cell progenitors were enriched in the
CD45
+Lin
2 subset, which contained most of the NK progenitors.
However, the CD45
+Lin
2 subset was about 5% of the bulk ES-
HPs while the enrichment of T cell progenitors was only about
three fold, suggesting that T cell progenitors were also contained in
other subsets of ES-HPs.
To test the B cell potential of ES-HPs, CD45
+Lin
2 ES-HPs
were sorted and cultured on OP9 with IL-7 and Flt3-L for one
week. B cells were detected in the culture by the expression of
B220 and CD19 (Fig. 5E). Therefore, CD45
+Lin
2 ES-HPs
contained B cell potential. To test whether these cells also have
myeloid differentiation potential, sorted CD45
+Lin
2 ES-HPs were
Table 1. Frequency of NK progenitors in EB and ES-HP
subpopulations
......................................................................
Cells tested NK progenitor frequency (% 6 SD)
{
CD34
+CD45
2 EB 0.1660.03
CD45
+ ES-HP
* 1.961.2
CD45
2 ES-HP
* 0.3560.05
Bulk ES-HP
* 0.5
#
CD45
+Mac-1
2Ter119
2 ES-HP
** 1065.1
Bulk ES-HP
** 0.460.15
{Progenitor frequency was determined by sorting limiting numbers of cells into
96 well plates containing OP9 stroma and media for NK differentiation cultures
as described in materials and methods. NK cells were detected by granzyme B
RT-PCR.
*Derived from CD34
+ EB cells.
**Derived from CD34
+CD45
2 EB cells.
#Average of two independent experiments. All other values are average of
three independent experiments.
doi:10.1371/journal.pone.0000232.t001
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Figure 2. Characterization of NK progenitors within ES-HPs. (A) ES-HP
cells were stained for the indicated markers and analyzed by flow
cytometry. Filled histograms show staining with appropriate mAbs and
open histograms show isotype-matched control antibody staining.
Percentages of positively stained cells over the control staining are
shown. Dead cells were stained with propidium iodide and gated out.
OP9 cells were also gated out by their high scatter profile. (B) ES-HPs
were co-stained with anti-CD45.2 and IL-7Ra mAbs (left panel), or anti-
CD45.2 and cc mAbs (right panel) and analyzed by flow cytometer as in
(A). CD45 positive cells were gated and analyzed for the expression of
indicated receptors. (C) Irradiated OP9 cells were cultured for 2 days in
96 well plates. ES-HPs were stained with anti-CD45.2 mAb and CD45
+
and CD45
2 ES-HPs were sorted by FACS into the wells with the pre-
formed OP9 stroma layers. For CD45
+ ES-HPs, 10, 30 and 100 cells per
well were sorted into 12 wells each. For CD45
2 and bulk ES-HPs, 30, 100
and 300 cells per well were sorted into 12 wells each. After culturing
with appropriate cytokines for NK cell differentiation, cells in individual
wells were harvested and analyzed for the presence of NK cells by
granzyme B RT-PCR. Statistical analysis was performed using L-Calc
TM
software. The results are means 6 SD of three independent
experiments, except for bulk ES-HPs which is average of two
experiments.
doi:10.1371/journal.pone.0000232.g002
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+CD45
+ and CD34
+CD45
2 EB cells. (A) EBs were harvested on day 8 and single cell suspension was prepared.
Cells were stained with anti-CD34 mAb together with mAb to indicated markers and analyzed by flow cytometry. Dead cells were gated out by
propidium iodide staining. (B) CD34
+CD45
2 (left) and CD45
+ (right) EB cells in (A) were gated, and analysed for the expression of Mac-1 by flow
cytometry. Numbers indicate percentage of cells in quadrants or gates. (C) CD34
+CD45
2 and CD45
+ EB cells were isolated by FACS sorting and
cultured to generate ES-HPs. The sorted EB cells and the ES-HPs generated from them were plated for myeloid and erythroid colony formation as in
Fig. 1F. (D) CD34
+CD45
2 EB cells were directly cultured on OP9 stroma with IL-2 and IL-15 for NK cell differentiation. Cells were harvested after 2
weeks, stained for NK markers and analyzed by flow cytometry as in Fig. 1B. (E) CD34
+CD45
2 EB cells were directly cultured onto OP9-DL1 stroma
with proper cytokines for T cell differentiation for 3 weeks. Expression of T cell markers was analyzed by flow cytometry as in Fig. 1E. (F) Limiting
numbers (100, 300 and 1,000 cells per well) of CD34
+CD45
2 EB cells were sorted into each well of 96 well plates. For NK progenitor assays, wells
contained OP9 stroma, IL-2, and IL-15. For T progenitor assays, wells contained OP9-DL1 cells, IL-7 and Flt3-L as described in materials and methods.
NK cells were detected by granzyme B RT-PCR and T cells detected by TCRc RT-PCR followed by southern blotting. The number of progenitors in 1000
plated cells was calculated as in Fig. 2C.
doi:10.1371/journal.pone.0000232.g003
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PLoS ONE | www.plosone.org 6 February 2007 | Issue 2 | e232Figure 4. Characterization of ES-HP cells derived from CD34
+CD45
2 EBs for surface markers and NK potential. (A) ES-HP cells derived from
CD34
+CD45
2 EB cells were stained with mAbs to indicated markers and analyzed by flow cytometry as in Fig. 2A. (B) ES-HP cells were co-stained with
anti-CD45, c-kit and Sca-1 mAbs. Cells were then gated on CD45
+ and analyzed for the expression of c-kit and Sca-1 (left panel). ES-HP cells were
stained with a combination of purified anti-CD45.2 mAb followed by Alexa Flour 647-goat anti-mouse IgG, and biotinylated anti-Mac-1 and Ter119
mAbs followed by streptavidin-PE and analyzed by flow cytometer (middle panel). CD45
+Mac-1
2Ter119
2 cells were gated and analyzed for the
expression of IL-2Rb (right panel). (C) CD45
+Lin
2 ES-HPs were sorted and cultured on OP9 stroma with IL-2 and IL-15. After 3 days, cells were
harvested and subjected to flow cytometry analysis after staining with anti-IL-2Rb and anti-IL-7Ra. (D) Sorted CD45
+Lin
2 ES-HPs were cultured in NK
culture (described in materials and methods) for one week and analysed for the expression of NK markers. (E) The bulk and sorted CD45
+Lin
2 ES-HP
cells were analyzed for NK progenitor frequency by limiting dilution cultures as in Fig. 2C. For the former 30, 100 and 300 cells per well and for the
latter 3, 10, and 30 cells per well were plated. The results are mean 6 SD of three independent experiments.
doi:10.1371/journal.pone.0000232.g004
NK Development from ES Cells
PLoS ONE | www.plosone.org 7 February 2007 | Issue 2 | e232Figure 5. T, B and myeloid potential of ES-HPs derived from CD34
+CD45
2 EB cells. (A) CD34
+CD45
2 EB cells were sorted and cultured with OP9
and cytokines to generate ES-HPs. They were then cultured on OP9-DL1 stroma with cytokines for T cell differentiation. At different time points, cells
were harvested and stained for CD44 and CD25 and analyzed by flow cytometer. Dead cells were stained with propidium iodide and OP9-DL1 cells
expressing green fluorescent protein were gated out. The numbers show the percentages of cells in the quadrants. (B) ES-HP cells were cultured for T
cell differentiation for 8 days with 5 ng/ml IL-7 as in (A). On day 8, IL-7 concentration was reduced to 1 ng/ml and cells were cultured for an additional
6 days. Cells were harvested and analyzed by flow cytometer for CD4 and CD8 expression. The numbers indicate the percentages of cells in the
quadrants. (C) ES-HP cells were cultured for T cell differentiation with 5 ng/ml IL-7 for 2 weeks and an additional 4 days with 1 ng/ml IL-7, stained for
TCRcd and TCRb and analyzed by flow cytometer. The numbers show the percentages of cells positively stained with the test antibodies (filled
histogram) over control antibody (open histogram). (D) ES-HPs were generated from CD34
+CD45
2 EB cells as in (A). The bulk and sorted CD45
+Lin
2
ES-HP cells were analyzed for T progenitor frequency by limiting dilution cultures as in Fig. 3F, except that 30, 100, 300 and 900 cells per well for bulk
and 10, 30 and 100 cells per well for CD45
+Lin
2 cells were plated. The results are average of two independent experiments. (E) CD45
+Lin
2 ES-HPs
were sorted and cultured on OP9 cells with IL-7 and Flt3-L for B cell generation. After one week, cells were harvested and analysed for the expression
of B220 and CD19 with flow cytometer. (F) One thousand sorted CD45
+Lin
2 ES-HPs were transferred into myeloid differentiation media as in Fig. 1F.
The number of myeloid and erythroid colonies were scored.
doi:10.1371/journal.pone.0000232.g005
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PLoS ONE | www.plosone.org 8 February 2007 | Issue 2 | e232transferred into methylcellulose for myeloid colony formation. On
average, 5.7% of CD45
+Lin
2 ES-HPs formed erythro/myeloid
colonies (Fig. 5F). These results indicate that ES-HPs have NK, T,
B and myeloid/erythroid potentials.
DISCUSSION
We have characterized NK cell progenitors at various stages of
development from ES cells in vitro. The most immature
progenitors with NK cell potential are found among EB cells
expressing CD34 but not the pan-leukocyte marker CD45. When
cultured on OP9 stroma in the presence of IL-7, IL-6, Flt3-L and
SCF, CD34
+CD45
2 EB cells differentiate into a heterogeneous
cell population, which we termed ES-HP (ES cell-derived
hematopoietic progenitors). Among ES-HPs, NK cell progenitors
are highly enriched in a subpopulation expressing CD45 but not
the mature erythroid and myeloid cell lineage markers Ter119 and
Mac-1. Thus, CD34
+CD45
2 immature hematopoietic progenitors
in EBs differentiate into more mature CD45
+ NK progenitors in
this culture. Since CD34
+CD45
2 EB cells are heterogeneous, the
relationship between NK progenitors in the EB cell population
and those among ES-HPs is still unclear. However, the difference
in CD45 expression indicates that NK progenitors among ES-HPs
are not products of simple amplification of NK progenitors in EB
but rather they are differentiation products derived from immature
hematopoietic progenitors in EBs.
The overall ES-HP cell population is rather heterogeneous and
contains myeloid and erythroid cells at various stages of
development as well as CD45
2Lin
2 cells, which mostly includes
immature hematopoietic progenitors (unpublished data, 2007).
Most, if not all, NK progenitors are in the CD45
+Lin
2
(Ter119
2Mac-1
2) subset. The frequency of NK progenitors in
this subset, as determined by limiting dilution assay, is about 10%,
which is comparable to that of adult mouse BM NKPs defined by
CD122
+Lin
2 [2]. However, there are some differences between
NKP in BM and those in ES-HPs. Most notably, BM NKPs
express CD122 [2] whereas it is undetectable on those among ES-
HPs (Fig. 4B, right panel). It is likely that NK progenitors at the
ES-HP stage are more immature than BM NKPs. CD122
2 NK
progenitors, which mature into CD122
+ progenitors, have been
found in human lymph nodes as well [26]. As expected, NK
progenitors in the ES-HP population rapidly acquire CD122
during their maturation to NK cells (Fig. 4C).
The frequency of T progenitors in bulk ES-HPs is significantly
higher than that among EBs (1 in 297 versus 1 in 1266,
respectively), indicating a T cell developmental intermediate is
generated in ES-HP culture. However, the enrichment of T cell
progenitors in CD45
+Lin
2 ES-HP fraction compared to bulk
population was much less than that of NK progenitors (three fold
versus 25 fold). Nevertheless, these results show that T progenitors
co-exist with NK progenitors in the same cell population. It is still
unclear whether ES-HPs include bipotent T/NK progenitors.
Both T and NK cells are generated in bulk cultures to induce
differentiation of CD45
+Lin
2 ES-HPs into T cells. However, the
results with limiting dilution analysis show that the frequency of T
cell progenitors among CD45
+Lin
2 ES-HPs is low (less than 1%).
Our attempt to determine the frequency of progenitors that give
rise to both NK and T cells by limiting dilution assays on OP9-
DL1 cells have resulted in rather inconsistent results (data not
shown). One of the difficulties in determining T cell progenitor
frequency in this study is that most T cell progenitors do not
differentiate into mature T cells expressing the TCR, CD3, CD4
or CD8 in our cultures as their differentiation is blocked at the
DN2 stage before TCRc gene rearrangement, which was used to
detect T cells in the limiting dilution analysis. Thus, the frequency
of T cell progenitors is likely very much underestimated in our
study, making it difficult to detect bipotent T/NK progenitors.
Nevertheless, our study has shown that CD45
+Lin
2 ES-HPs
include both NK and T cell progenitors. We also showed that
CD45
+Lin
2 ES-HPs have B cell and myeloid potentials. Thus
CD45
+Lin
2 ES-HPs likely comprise of multiple committed
progenitors. However, it is also possible that CD45
+Lin
2 ES-
HPs include multi-potent hematopoietic progenitors which are
downstream progeny of CD45
2 progenitors.
Our study has also shown that CD34
+ EB cells are rather
heterogeneous and include both CD45
+ and CD45
2 cells.
Although the relationship between these two subsets of CD34
+
EB cells is still unclear, the former includes erythroid/myeloid
colony forming cells but no lymphoid progenitors whereas the
latter has both myeloid/erythroid and lymphoid potentials. Since
CD34
+CD45
+ EB cells express Mac-1 (Fig. 3B) , it is possible that
these cells are myeloid precursors that have derived from CD45
2
EB cells generated earlier in the EBs. CD45
+ macrophage
precursors have been described during early embryonic de-
velopment in aorta-gonad-mesonephros (AGM) region [27]. On
the other hand, CD45
2 EB cells resemble precursors found in
paraaortic splanchnopleura (P-Sp) and AGM region which
generate lymphocytes and also lack CD45 [27,28]. Through an
in vitro differentiation system, for the first time, we have
demonstrated a differentiation pathway in which these cells
acquire CD45 during ES-HP stage before subsequent differenti-
ation to individual hematopoietic lineages. It will be interesting to
compare the reconstitution capacity of CD45
2 EBs and that of
CD45
+Lin
2 ES-HPs. While EB cells have been shown to
reconstitute adult BM only by overexpression of HoxB4 [29]
and/or Cdx4 [30], CD45
+ ES-HPs may be developmentally closer
to adult HSCs and give rise to multilineage engraftment without
a need for genetic modifications.
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